AUSTIN, Texas, July 27, 2012 (GLOBE NEWSWIRE) —, Inc. announced today that a new audio interview with Ingen Technologies, Inc. (Pink Sheets:IGNT), an emerging medical device manufacturer with proprietary products for the growing $4B respiratory markets, is now available. The interview can be heard at

The interview includes an overview of the massive market IGNT services through its patented and proprietary Oxyview product line, the goals for the company in 2012 and the major achievements of the company to date.

Ingen Technologies recently announced that the company placed its Oxyview product line with a leading national medical supplier for the home healthcare and hospital markets. is a recognized corporate investor relations firm, with clients nationwide, known for its ability to help emerging growth companies build a following among retail and institutional investors. utilizes its stock newsletter to feature its daily stock picks, audio interviews, as well as its clients’ financial news releases. also offers individual investors all the tools they need to make informed decisions about the stocks they are interested in. Tools like stock charts, stock alerts, and Company Information Sheets can assist with investing in stocks that are traded on the OTC BB and Pink Sheets. To learn more about and their services, please visit


Like us on Facebook

Follow us on Twitter!/smallcapvoice

Safe Harbor for Forward-Looking Statements: This news release includes forward-looking statements. While these statements are made to convey to the public the company’s progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management’s opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company’s operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are and will be set forth in the company’s periodic filings with the U.S. Securities and Exchange Commission.

CONTACT: Gary Tilden

Stuart T. Smith

Source: Globe Newswire (July 27, 2012 – 8:00 AM EDT)